Search Results - "Davis, Stanley S"

Refine Results
  1. 1

    Formulation strategies for absorption windows by Davis, Stanley S.

    Published in Drug Discovery Today (15-02-2005)
    “…The transit of a drug (formulation) through the GI tract will determine how long a compound will be in contact with its preferred absorptive site. A good…”
    Get full text
    Book Review Journal Article
  2. 2

    Absorption enhancers for nasal drug delivery by DAVIS, Stanley S, ILIUM, Lisbeth

    Published in Clinical pharmacokinetics (01-01-2003)
    “…This paper describes the basic concepts for the transmucosal delivery of drugs, and in particular the use of the nasal route for delivery of challenging drugs…”
    Get full text
    Journal Article
  3. 3

    Advances in the use of tocols as drug delivery vehicles by CONSTANTINIDES, Panayiotis P, JIHONG HAN, DAVIS, Stanley S

    Published in Pharmaceutical research (01-02-2006)
    “…There has been increasing interest in recent years in the drug delivery applications of tocols and their derivatives. Their biocompatibility and potential to…”
    Get full text
    Journal Article
  4. 4

    Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model by Charlton, Stuart T., Whetstone, Joanne, Fayinka, Susan T., Read, Kevin D., Illum, Lisbeth, Davis, Stanley S.

    Published in Pharmaceutical research (01-07-2008)
    “…Purpose The aim of this study was to investigate and quantify drug movement to the brain via the neuro-olfactory system after intranasal dosing of four model…”
    Get full text
    Journal Article
  5. 5

    LEAPT: Lectin-Directed Enzyme-Activated Prodrug Therapy by Robinson, Mark A., Charlton, Stuart T., Garnier, Philippe, Wang, Xiang-tao, Davis, Stanley S., Perkins, Alan C., Frier, Malcolm, Duncan, Ruth, Savage, Tony J., Wyatt, David A., Watson, Susan A., Davis, Benjamin G., Langer, Robert

    “…Targeted drug delivery to selected sites allows reduced toxicity, enhanced efficiency and interchangeable target potential [Langer, R. (2001) Science 293,…”
    Get full text
    Journal Article
  6. 6

    Physical properties and stability of two emulsion formulations of propofol by Han, Jihong, Davis, Stanley S., Washington, Clive

    Published in International journal of pharmaceutics (14-03-2001)
    “…We have compared the physical properties of two commercial emulsion formulations of the intravenous anaesthetic propofol, (Diprivan®, AstraZeneca, and Propofol…”
    Get full text
    Journal Article
  7. 7

    Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability by Han, Jihong, Davis, Stanley S, Papandreou, Catherine, Melia, Colin D, Washington, Clive

    Published in Pharmaceutical research (01-09-2004)
    “…The current formulation of paclitaxel contains ethanol and Cremophor EL and has been reported to cause serious adverse reactions. The purpose of the present…”
    Get full text
    Journal Article
  8. 8

    Design and Evaluation of an Emulsion Vehicle for Paclitaxel. II. Suppression of the Crystallization of Paclitaxel by Freeze-Drying Technique by Han, Jihong, Washington, Clive, Davis, Stanley S.

    Published in Drug development and industrial pharmacy (01-01-2007)
    “…Although paclitaxel is soluble in vitamin E up to 40 mg per g, crystallization was detected at loadings higher than 15 mg per g. Water appeared to be an…”
    Get full text
    Journal Article
  9. 9

    In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers by Dunn, Susan E, Coombes, Allan G.A, Garnett, Martin C, Davis, Stanley S, Davies, Martyn C, Illum, Lisbeth

    Published in Journal of controlled release (01-02-1997)
    “…Biodegradable poly(lactide-co-glycolide) (PLGA) nanospheres in the size range 80–150 nm have been produced, using an interfacial polymer deposition…”
    Get full text
    Journal Article
  10. 10

    The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery by Davis, Stanley S.

    Published in Vaccine (01-04-2006)
    “…It is important when developing new vaccine systems to give proper attention to the question of delivery. In some cases the judicious choice of a delivery…”
    Get full text
    Journal Article
  11. 11

    In vitro evaluation of the mucoadhesive properties of chitosan microspheres by He, Ping, Davis, Stanley S., Illum, Lisbeth

    Published in International journal of pharmaceutics (11-05-1998)
    “…The mucoadhesive properties of chitosan and chitosan microspheres were evaluated by studying the interaction between mucin and chitosan in aqueous solution by…”
    Get full text
    Journal Article
  12. 12

    Chitosan microspheres prepared by spray drying by He, Ping, Davis, Stanley S, Illum, Lisbeth

    Published in International journal of pharmaceutics (30-09-1999)
    “…Non-crosslinked and crosslinked chitosan microspheres were prepared by a spray drying method. The microspheres so prepared had a good sphericity and a smooth…”
    Get full text
    Journal Article
  13. 13

    Octanol−, Chloroform−, and Propylene Glycol Dipelargonat−Water Partitioning of Morphine-6-glucuronide and Other Related Opiates by Avdeef, Alex, Barrett, David A, Shaw, P. Nicholas, Knaggs, Roger D, Davis, Stanley S

    Published in Journal of medicinal chemistry (25-10-1996)
    “…The pK a and log P values of morphine-6-β-d-glucuronide (M6G) and morphine-3-β-d-glucuronide (M3G) and a range of structurally-related opiates (morphine,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system by Charlton, Stuart T., Davis, Stanley S., Illum, Lisbeth

    Published in Journal of drug targeting (01-01-2007)
    “…It has been shown that vasoconstrictive drugs such as ephedrine derivatives are able to decrease systemic absorption of drugs administered by mucosal surfaces…”
    Get full text
    Journal Article
  16. 16

    Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles by Lin, Wu, Garnett, Martin C., Davis, Stanley S., Schacht, Etienne, Ferruti, Paulo, Illum, Lisbeth

    Published in Journal of controlled release (12-03-2001)
    “…Surface-modified albumin nanoparticles were prepared from two poly(ethylene glycol)–human serum albumin conjugates: poly(thioetheramido acid)–poly(ethylene…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake by HAWLEY, A. E, ILLUM, L, DAVIS, S. S

    Published in Pharmaceutical research (01-05-1997)
    “…Nanospheres can be utilised for the targeting of drugs and diagnostic agents to the regional lymph nodes. The surface modification of model polystyrene, (PS),…”
    Get full text
    Journal Article
  19. 19

    Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers by STOLNIK, S, DUNN, S. E, ILLUM, L, GARNETT, M. C, DAVIES, M. C, COOMBES, A. G. A, TAYLOR, D. C, IRVING, M. P, PURKISS, S. C, TADROS, T. F, DAVIS, S. S

    Published in Pharmaceutical research (01-12-1994)
    “…The modification of surface properties of biodegradable poly(lactide-co- glycolide) (PLGA) and model polystyrene nanospheres by poly(lactide)-poly(ethylene…”
    Get full text
    Journal Article
  20. 20

    Structure and Mucoadhesion of Mussel Glue Protein in Dilute Solution by Deacon, Matt P, Davis, Stanley S, Waite, J. Herbert, Harding, Stephen E

    Published in Biochemistry (Easton) (06-10-1998)
    “…Purified mussel adhesive protein mefp-1 (Mytilus edulis foot protein 1) has been studied regarding its state of oligomerization and gross conformation in…”
    Get full text
    Journal Article